CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 205 enrolled
Drug / intervention
Vision device validationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03456245
NCT03456245N/ACompleted
CompareCT.gov

A Validation Study of Mobile Technologies for Assessing Visual Acuity and Eye Health Among Older Adults in India

Harvard School of Public Health (HSPH)·observational·Posted Mar 7, 2018·Updated Feb 24, 2020

In Brief

An observational study evaluating Vision device validation for Myopia and Hyperopia. Completed, enrolled 205 participants.

Detailed Summary

Study compares four portable vision measurement and eye-imaging technologies in terms of accuracy and time and ease of use with older adult (ages 40-100) participants in a developing-country setting (India). Specifically, the five portable devices will be measured against the baseline of the traditional eye-examination techniques, including the use of eye charts and phoropters.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Hyperopia
Countries--
CollaboratorsSankara Eye Hospital

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 7, 2018
Enrollment StartAug 15, 2016
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 16 daysPosted 8.3 years ago

Interventions

Vision device validationdevice

Group members had their vision tested with the following devices/methods: Eyenetra NETRA, PlenOptika Quicksee, Right Manufacturing Retinomax K Plus 3, and standard eyesight tests using eye charts, phoropters, and slit lens lamp imaging.